The U.S. FDA Partners with NASEM for Independent Study on Infant Formula Market Challenges and Regulation

The U.S. Food and Drug Administration (FDA) has announced a collaboration with the National Academies of Sciences, Engineering, and Medicine (NASEM) to conduct an independent study on the supply, market competition, and regulation of infant formula in the United States. This study aims to provide valuable insights into the current state of the U.S. infant formula market, including factors such as manufacturers' diversity, types of formulas produced, production capacity, and import-export dynamics.

Upon completion, NASEM will present a comprehensive report to Congress and the FDA, informing future strategies to enhance the resiliency and safety of the U.S. infant formula market. This initiative is part of the FDA's commitment to ensuring that consumers can trust the safety and nutritional quality of infant formula available in the country.